Butterfly iQ+ and Philips Lumify sit in the same pocus category but take different approaches. Butterfly iQ+ (Butterfly Network) uses Semiconductor-based ultrasound-on-a-chip (single probe, whole body) while Philips Lumify (Philips Healthcare) uses App-Based Handheld Ultrasound (3 transducer options). Both received FDA clearance (2020 and 2015 respectively) and both are actively sold in the US market. The decision between them is rarely about which is objectively better. It's about which fits your specific practice.
Physicians end up comparing these two devices when they're shopping in the $2,499-$3,999 (probe) + $420/yr (subscription) to $5,995-$9,995 (probe + subscription) price range and want a category leader. Both devices are commonly recommended by sales reps from competing manufacturers, which means physicians often hear inflated claims about one and dismissive claims about the other. This comparison strips out the marketing and looks at pricing, mechanism, evidence, and practice fit side by side.
Technology: Semiconductor-based ultrasound-on-a-chip (single probe, whole body). World's first ultrasound-on-a-chip. Single probe replaces entire cart of transducers. AI-assisted image quality and measurements.
Philips Lumify
Technology: App-Based Handheld Ultrasound (3 transducer options). First FDA-cleared smart-device ultrasound. Three PureWave transducer options (sector, linear, curved) let users mix-and-match coverage instead of paying for bundled hardware.
Pricing
Butterfly iQ+
New: $2,499-$3,999 (probe) + $420/yr (subscription). Used: $1,500-$2,500. Per session: N/A. Annual consumables: $420 (required cloud subscription). Annual maintenance: Included in subscription.
Philips Lumify
New: $5,995-$9,995 (probe + subscription). Used: $2,500-$5,000. Per session: N/A. Annual consumables: $400-$900 (subscription). Annual maintenance: Included in subscription.
Clinical Evidence
Butterfly iQ+
Growing body of evidence. Multiple studies comparing to cart-based systems across specialties.
Philips Lumify
40+ published studies. Strong cardiac and abdominal imaging comparison data against cart-based systems.
Treatment Experience
Butterfly iQ+
Point-of-care (as needed) per session. Recommended protocol: N/A (diagnostic tool). Treatment areas: Whole body (18 presets: cardiac, lung, MSK, abdominal, vascular, OB). Patients typically tolerate this platform well when operated by trained clinicians.
Philips Lumify
Point-of-care (as needed) per session. Recommended protocol: N/A (diagnostic tool). Treatment areas: Cardiac, Abdominal, OB, Vascular, Lung, MSK. Patient experience varies by operator training and settings.
Practice Fit
Butterfly iQ+
Primary care, urgent care, and emergency physicians who want bedside ultrasound capability without a $50K cart investment. Medical students and residents.
Philips Lumify
Cardiology, OB, and specialty practices that want single-application image quality. Buyers that already use Philips imaging and value brand continuity.
Pros and Cons
Butterfly iQ+ Pros
Lowest entry price for whole-body ultrasound ($2,499)
Single probe covers 18 presets (no transducer swapping)
AI-assisted image quality and auto-measurements
iPhone/iPad compatible and pocket-sized
Butterfly iQ+ Cons
Image quality below cart-based systems for specialized applications
Required annual subscription ($420/yr)
Battery life limits extended use
Philips Lumify Pros
Choice of three dedicated transducers for best image quality per application
Three transducers means three purchases for whole-body coverage
Subscription required for imaging and cloud storage
The Verdict
Choose Butterfly iQ+ if your practice prioritizes Butterfly Network's ecosystem, brand recognition, or specific clinical advantages. Primary care, urgent care, and emergency physicians who want bedside ultrasound capability without a $50K cart investment. Medical students and residents. The pros that matter most: Lowest entry price for whole-body ultrasound ($2,499); Single probe covers 18 presets (no transducer swapping). The biggest tradeoff to accept: Image quality below cart-based systems for specialized applications.
Choose Philips Lumify if Philips Healthcare's positioning fits better. Cardiology, OB, and specialty practices that want single-application image quality. Buyers that already use Philips imaging and value brand continuity. The pros that matter most: Choice of three dedicated transducers for best image quality per application; PureWave single-crystal transducer design delivers strong image quality. The biggest tradeoff to accept: Highest upfront cost among handheld POCUS options.
For a practice with limited capital that needs maximum flexibility, used pricing tilts the math. Butterfly iQ+ used units run $1,500-$2,500; Philips Lumify used units run $2,500-$5,000. For practices with strong patient flow already, the device that integrates with your existing platforms is usually the right answer even if its standalone specs are slightly weaker. For practices building a category from scratch, brand recognition and patient demand matter more than raw clinical specs. Look at which device patients are already asking for in your market before signing a contract.
One Probe vs Three: The Core Trade-off
Butterfly iQ+ uses a single probe with software-switchable modes to cover more than 20 scan types, from cardiac to MSK to OB. Philips Lumify sells dedicated transducers (curved, linear, and phased array) separately, each optimized for specific imaging tasks. The Butterfly approach wins on portability and simplicity. The Lumify approach wins on image quality for specialists who need the best picture in their specific domain.
For a primary care physician or hospitalist who needs a versatile bedside tool, Butterfly iQ+ at $2,499-$3,999 is hard to beat. For a cardiologist or OB physician who will use one transducer 90% of the time and demands the sharpest images, Lumify's dedicated probes at $5,995-$9,995 per transducer deliver noticeably better results in the target application.
Subscription Model Differences
Butterfly iQ+ requires a $420/year software subscription for full access to all scanning modes and cloud storage. Lumify requires a per-transducer subscription that varies but typically runs $600-$900/year per probe. Practices buying one Lumify transducer pay roughly the same annual subscription as Butterfly. Practices that need two or three Lumify transducers for different specialties will spend $1,200-$2,700/year in subscriptions. That gap changes the 5-year total cost of ownership math.
Both companies use the subscription model to lock in recurring revenue after the hardware sale. Neither is inherently predatory, but practices should model total cost over 5 years before buying either device. The hardware purchase is usually 40-60% of the true 5-year cost of ownership.
Practical Workflow Differences
Butterfly iQ+ connects to any iOS or Android device. The ultrasound chip lives in the probe. Setup time is under 30 seconds. Lumify also connects to iOS and Android via the Lumify app. Both support real-time image review and annotation directly on a smartphone or tablet.
The workflow difference shows up at the point of care. Butterfly handles a broader range of patients from one probe without swapping. Lumify requires transducer selection upfront, which adds 60-90 seconds per patient but delivers better images for that patient's specific indication. Emergency medicine physicians and intensivists overwhelmingly prefer Butterfly for this reason. Cardiology and radiology-adjacent specialists often prefer Lumify.
Frequently Asked Questions
Which is more expensive, Butterfly iQ+ or Philips Lumify?
Butterfly iQ+ runs $2,499-$3,999 (probe) + $420/yr (subscription) new and $1,500-$2,500 used. Philips Lumify runs $5,995-$9,995 (probe + subscription) new and $2,500-$5,000 used. Per-session pricing is N/A for Butterfly iQ+ and N/A for Philips Lumify. Annual operating costs (consumables plus maintenance) typically run 5-15% of purchase price for both devices. The right financial comparison includes total cost of ownership over 5 years, not just sticker price.
Which has better clinical evidence, Butterfly iQ+ or Philips Lumify?
Butterfly iQ+ clinical evidence: Growing body of evidence. Multiple studies comparing to cart-based systems across specialties. Philips Lumify clinical evidence: 40+ published studies. Strong cardiac and abdominal imaging comparison data against cart-based systems. Evidence quality is not about study count alone. Look at sample sizes, blinded evaluators, independence from manufacturer funding, and outcome durability. Older devices in the same category usually have stronger evidence because they've been studied longer.
Is Butterfly iQ+ or Philips Lumify more popular in emergency medicine practices?
Both Butterfly iQ+ and Philips Lumify are commonly used in emergency medicine, internal medicine, family medicine practices. Market share in any given category shifts year to year. Butterfly Network and Philips Healthcare both maintain active sales forces in the US. Ask other physicians in your specialty which platform they're using and why. Peer references in your local market matter more than national market share data.
Are there safety concerns with Butterfly iQ+ or Philips Lumify?
Both devices are FDA cleared and have established safety profiles. Butterfly iQ+ has these documented concerns: Image quality below cart-based systems for specialized applications. Philips Lumify has: Highest upfront cost among handheld POCUS options. Physicians should monitor FDA MAUDE reports for both devices before purchase. Adverse event trends matter because they signal problems that may not appear in marketing materials. Any device with a sudden spike in MAUDE filings deserves closer scrutiny.
Can I use Butterfly iQ+ and Philips Lumify in the same practice?
Some practices run both devices, especially when they target different patient segments or treatment areas. The downside is duplicated training, parallel consumable inventories, and potential cannibalization between platforms. The upside is broader marketing claims and the ability to switch patients between platforms if one doesn't deliver expected results. Most practices choose one and commit to mastering it rather than splitting volume.
What's the resale value comparison between Butterfly iQ+ and Philips Lumify?
Used Butterfly iQ+ sells for $1,500-$2,500 on the secondary market. Used Philips Lumify sells for $2,500-$5,000. Resale values depend on age, software version, applicator condition, and remaining warranty. Devices with strong installed bases hold value better. Devices with active safety signals or declining manufacturer financial health depreciate faster. Resale value should be a factor in any device purchase, especially if practice plans might change in 3-5 years.
Butterfly iQ+ vs Philips Lumify: which is better for emergency medicine practices in 2026?
For emergency medicine practices specifically in 2026, the choice between Butterfly iQ+ and Philips Lumify depends on three factors: existing equipment compatibility (does the new device integrate with what you already run), patient mix and treatment volume (high-volume practices typically benefit from Butterfly iQ+'s lowest entry price for whole-body ultrasound ($2,499) while lower-volume practices often prefer Philips Lumify's choice of three dedicated transducers for best image quality per application), and total cost of ownership over 5 years including consumables and maintenance. Run the side-by-side TCO analysis with realistic patient volume projections before committing to either platform.
Butterfly iQ+ vs Philips Lumify: 2026 update on features and clinical evidence?
As of April 2026, both Butterfly iQ+ and Philips Lumify continue commercial availability from Butterfly Network and Philips Healthcare respectively. Recent updates worth tracking: software releases, new applicator launches, expanded FDA labeling indications, and new peer-reviewed clinical evidence publications. Manufacturer financial stability also matters for long-term support and parts availability. Both manufacturers publish quarterly financial results that inform the long-term outlook for each device.
How do I choose between Butterfly iQ+ and Philips Lumify for my practice?
Use a structured decision framework: list 5-7 must-have requirements specific to your patient mix and practice economics, score Butterfly iQ+ and Philips Lumify against each requirement on a 1-5 scale, weight the requirements by importance, then sum the weighted scores. The platform that scores meaningfully higher (10%+ gap) is the right choice. If the scores are within 10%, secondary factors decide: manufacturer relationship, financing terms, training availability, and resale value. Avoid choosing based on feature breadth alone because most devices in this category have similar feature checkboxes. The differentiation is in workflow fit, treatment results, and total cost over 5 years.
Are there better alternatives to Butterfly iQ+ or Philips Lumify in the pocus category?
In the pocus category, Butterfly iQ+ and Philips Lumify are often the leading platforms but other alternatives may fit specific practice profiles better. Other category options include ge-vscan-air, clarius-hd3, kosmos. Run a 4-platform shortlist evaluation rather than a 2-platform binary because hidden alternatives sometimes outperform on the metrics that matter most to your specific practice.